Immunobiology and Immunotherapy of Cancer

癌症的免疫生物学和免疫治疗

• 批准号: nhmrc : GNT1132373
• 负责人: A/Pr Michael Kershaw
• 金额: $ 1320.24万
• 依托单位国家: 澳大利亚
• 项目类别: Programs
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/immunobiology-immunotherapy-cancer/1347832
• 关键词: Immunobiology; Immunotherapy; Cancer

For 60 years, we have had only 3 effective cancer treatments: surgery, radiation and chemotherapy, often used in combination.The last 5 years have produced a powerful fourth treatment: the patient's own immune system.The long standing collaborations and synergies of our multi-disciplinary teams have already underpinned many recent advances in immune-based therapies: we are now poised to develop several further immunotherapies and on track to test them in patients during the term of this grant.

60年来，我们只有三种有效的癌症治疗方法：手术、放疗和化疗，通常联合使用。最近5年，我们产生了第四种强大的治疗方法：患者自身的免疫系统。我们多学科团队的长期合作和协同作用已经为免疫疗法的许多最新进展奠定了基础：我们现在正准备进一步开发几种免疫疗法，并有望在这笔赠款的有效期内在患者身上进行测试。